Pages that link to "Q38197344"

The following pages link to Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications (Q38197344):

Displaying 14 items.

• Metformin Scavenges Methylglyoxal To Form a Novel Imidazolinone Metabolite in Humans. (Q33727050) (← links)
• The glucose metabolite methylglyoxal inhibits expression of the glucose transporter genes by inactivating the cell surface glucose sensors Rgt2 and Snf3 in yeast. (Q36716401) (← links)
• Enhanced Approaches for Identifying Amadori Products: Application to Peanut Allergens. (Q36745378) (← links)
• Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial (Q37710285) (← links)
• Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes (Q38524435) (← links)
• Glyoxalase biochemistry (Q38629015) (← links)
• Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial (Q38725515) (← links)
• Pathways of the Maillard reaction under physiological conditions (Q38862611) (← links)
• A new perspective on metformin therapy in type 1 diabetes (Q41354131) (← links)
• Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury (Q41449206) (← links)
• Diphlorethohydroxycarmalol Attenuates Methylglyoxal-Induced Oxidative Stress and Advanced Glycation End Product Formation in Human Kidney Cells. (Q54949436) (← links)
• Derivatization of Methylglyoxal for LC-ESI-MS Analysis-Stability and Relative Sensitivity of Different Derivatives (Q59799233) (← links)
• Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans (Q64083177) (← links)
• Metformin Delays the Development of Atherosclerosis in Type 1 Diabetes Mellitus via the Methylglyoxal Pathway (Q92751996) (← links)